Syndax Presents Positive Pediatric Data from Pivotal AUGMENT

WALTHAM - Syndax Pharmaceuticals , a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the presentation of positive data from the pivotal...

Related Keywords

Seattle , Washington , United States , American , Neil Gallagher , Sharon Klahre , Syndax Pharmaceuticals , Time Oncology Review Program , Exchange Commission , American Society Of Hematology Annual Meeting , American Society Of Pediatric Hematology Oncology , European Commission , Head Of Research , Plenary Session , Pivotal Phase , Acute Leukemia , Pediatric Experience , Hematology Annual , Orphan Drug Designation , Fast Track , Breakthrough Therapy Designation , New Drug Application , Priority Review , Prescription Drug User Fee Act , Real Time Oncology Review , Rearranged Acute , Private Securities Litigation Reform Act , Risk Factor , News Publishing , Markets ,